Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Exercise/Conversion of 1,000 PVLA shares, $13.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | PALVELLA THERAPEUTICS, INC. (PVLA) | Exercise/Conversion | 1,000 | $13.6K |
| Jun 5, 2026 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/Award | 25,907 | n/a |
| Feb 9, 2026 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/Award | 44,123 | n/a |
| Jul 17, 2025 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/Award | 19,506 | n/a |
| Dec 18, 2024 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/Award | 167,100 | n/a |
| Sep 24, 2024 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 4,982 | $249.1K |
| Sep 18, 2024 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 914 | $51.0K |
| Aug 27, 2024 | LIGAND PHARMACEUTICALS INC (LGND) | Sale | 1,157 | $122.1K |
| Aug 21, 2024 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/Award | 24,554 | n/a |
| Aug 13, 2024 | LIGAND PHARMACEUTICALS INC (LGND) | Sale | 18,245 | $1.80M |